Delivery Order SPE2DB20D3101-SPE2DB25FRKS0

Award Date 5/19/25
Potential Completion Date 5/20/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of KLOR-CON M20 tablets. The contract has a ceiling value of $2,750.78 and an ultimate completion date of May 6, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999.00, which provides comprehensive global pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,912.25 firm fixed-price contract is for the delivery of KLOR-CON M20 Tablets, a potassium supplement medication, with a performance period through August 30, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies to supply a wide range of pharmaceutical and medical products to support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of KLOR-CON M20 tablets, a medication used to treat potassium deficiency. The contract has a firm fixed price of $1,351.58 and a period of performance ending on May 6, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA, valued at $999,999,999.00, which...
This federal contract award, with a GovTribe ID of SPE2DB20D1004|SPE2DB25FNGVS, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,391.93 firm fixed-price delivery order is for the supply of KLOR-CON M20 TABLET 500S, a medication used for the treatment of various medical conditions. The contract has an ultimate completion date of May 7, 2025. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $2,149.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,142,826 potassium chloride extended-release tablets, 500 tablets per bottle. The contract is not set aside and has an ultimate completion date of May 6, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,290.24, is for the delivery of 4567874687 - Potassium Cl ER 20 MEQ Tablet 500s. The contract is a Firm Fixed Price, non-set-aside award with an ultimate completion date of April 11, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,336,705 potassium chloride extended-release tablets in 500 count bottles, with a ceiling value of $4,947.66. The contract is a firm fixed-price agreement with a performance period ending on May 23, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office Division of Amerisourcebergen Corporation. The contract is for the supply of a pharmaceutical product, KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, with a firm fixed price ceiling value of $1,420.91 and a completion date of July 11, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This federal contract award, valued at $1,009.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. (doing business as Amerisourcebergen) holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a...
This is a delivery order contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4560815782 - Potassium Cl ER 20 MEQ Tablet 100s, with a ceiling value of $1,100.40 and a completion date of May 4, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB25FRKS0
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of KLOR-CON M20 TABLET 1000S, a pharmaceutical product, with a ceiling value of $1,065.26 and a period of performance through May 20, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This prime contract allows for multiple delivery orders across different therapeutic categories, positioning Amerisourcebergen as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 8/18/25, 9:53 AM